132 / 1631
Two-Arm Parallel Phase 2 Clinical Trial of Atezolizumab with or
without Low Dose Local Radiotherapy (2 x 2Gy) in Patients with
Relapsed/Refractory Advanced Stage Follicular Lymphoma
PI: M. Lia Palomba
Primary Objective
ORR for atezolizumab vs atezolizumab + single site IRT
(2x2Gy)
Secondary Objectives
PFS and OS for atezolizumab vs atezolizumab + single site
IRT (2x2Gy), Safety
Exploratory objectives
Mandatory biopsies. Immune monitoring correlatives.